InsidersTradesSigma
Total declarations
Companies
▲ Purchases (22 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
22
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Theuer Charles, Chairman & CEO. Insider active across 2 companies, notably Tracon Pharmaceuticals, Inc.. In total, 25 reports have been published. Breakdown: 22 buys · 0 sell. Total volume traded: €196k. Activity tracked since 16 August 2021. The latest transaction was disclosed on 12 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Theuer Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
9,333 shares@ US$1.14100.0% of flowCommon StockSEC:0001193125-25-320992:0
3,500 shares@ US$0.13770.2% of flowCommon StockSEC:0001415889-24-007846:0
3,999 shares@ US$0.661.1% of flowCommon StockSEC:0001209191-23-025930:0
Canonical exit: 25 Jul 2023 (T+90)
200 shares@ US$1.520.1% of flowCommon StockSEC:0001209191-23-014434:0
Canonical exit: 29 May 2023 (T+90)
6,800 shares@ US$1.624.9% of flowCommon StockSEC:0001209191-23-003934:0
Canonical exit: 18 Apr 2023 (T+90)
23,000 shares@ US$1.293713.3% of flowCommon StockSEC:0001209191-22-061329:0
Canonical exit: 14 Mar 2023 (T+90)
13,900 shares@ US$1.419.0% of flowCommon StockSEC:0001209191-22-058302:0
Canonical exit: 16 Feb 2023 (T+90)
9,200 shares@ US$1.526.8% of flowCommon StockSEC:0001209191-22-055687:0
Canonical exit: 1 Feb 2023 (T+90)
6,000 shares@ US$1.594.6% of flowCommon StockSEC:0001209191-22-055435:0
Canonical exit: 31 Jan 2023 (T+90)
5,000 shares@ US$1.774.3% of flowCommon StockSEC:0001209191-22-053202:0
Canonical exit: 5 Jan 2023 (T+90)
5,000 shares@ US$1.674.0% of flowCommon StockSEC:0001209191-22-052605:0
Canonical exit: 1 Jan 2023 (T+90)
5,000 shares@ US$1.764.3% of flowCommon StockSEC:0001209191-22-051200:0
Canonical exit: 21 Dec 2022 (T+90)
4,500 shares@ US$1.853.9% of flowCommon StockSEC:0001209191-22-043061:0
Canonical exit: 20 Oct 2022 (T+90)
3,000 shares@ US$1.872.7% of flowCommon StockSEC:0001209191-22-042093:0
Canonical exit: 10 Oct 2022 (T+90)
10,000 shares@ US$1.858.9% of flowCommon StockSEC:0001209191-22-028188:0
Canonical exit: 7 Aug 2022 (T+90)
2,500 shares@ US$1.972.4% of flowCommon StockSEC:0001209191-22-027975:0
Canonical exit: 4 Aug 2022 (T+90)
5,000 shares@ US$1.97094.8% of flowCommon StockSEC:0001209191-22-026562:0
Canonical exit: 28 Jul 2022 (T+90)
4,500 shares@ US$2.304.9% of flowCommon StockSEC:0001209191-22-025471:0
Canonical exit: 20 Jul 2022 (T+90)
2,000 shares@ US$2.502.3% of flowCommon StockSEC:0001209191-22-024070:0
Canonical exit: 7 Jul 2022 (T+90)
4,000 shares@ US$2.704.9% of flowCommon StockSEC:0001209191-22-021876:0
Canonical exit: 28 Jun 2022 (T+90)
1,200 shares@ US$2.451.4% of flowCommon StockSEC:0001209191-22-020678:0
Canonical exit: 19 Jun 2022 (T+90)
681 shares@ US$2.880.9% of flowCommon StockSEC:0001209191-21-066096:0
Canonical exit: 16 Feb 2022 (T+90)
1,000 shares@ US$3.411.5% of flowCommon StockSEC:0001209191-21-063520:0
Canonical exit: 3 Feb 2022 (T+90)
3,000 shares@ US$3.564.6% of flowCommon StockSEC:0001209191-21-052132:0
Canonical exit: 14 Nov 2021 (T+90)
90,900 sharesCommon StockSEC:0001209191-16-093436:0
25 of 25 declarations
About Theuer Charles
THEUER CHARLES is Président-Directeur Général and is linked to Tracon Pharmaceuticals, Inc. as PRESIDENT AND CEO, as well as 4D Molecular Therapeutics, Inc. as Director. He has 25 filings in total, and across the 25 sampled filings, acquisitions total EUR 195721, with no sales, between 2016-01-25 and 2025-12-16.
